Previous 10 | Next 10 |
PLEASANTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders ...
PLEASANTON, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders f...
PLEASANTON, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorder...
Natus Medical Incorporated (NTUS) Q3 2020 Results Conference Call October 29, 2020 4:30 PM ET Company Participants Jonathan Kennedy - President and Chief Executive Officer Drew Davies - Executive Vice President and Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond ...
Image source: The Motley Fool. Natus Medical Incorporated (NASDAQ: NTUS) Q3 2020 Earnings Call Oct 29, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Natus Medical Incorporated (NTUS) Q3 2020 Earnings Call Transcri...
Natus Medical (NTUS): Q3 Non-GAAP EPS of $0.09 beats by $0.08; GAAP EPS of $0.28 beats by $0.39.Revenue of $102.8M (-16.7% Y/Y) beats by $8.4M.Press Release For further details see: Natus Medical EPS beats by $0.08, beats on revenue
PLEASANTON, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disord...
PLEASANTON, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders ...
PLEASANTON, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...
Natus Medical Incorporated (NTUS) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET Company Participants Jonathan Kennedy - President and Chief Executive Officer Drew Davies - Executive Vice President and Chief Financial Officer Conference Call Participants Jayson Bed...
News, Short Squeeze, Breakout and More Instantly...
Natus Medical Incorporated Company Name:
NTUS Stock Symbol:
NYSE Market:
Natus Medical Incorporated Website:
SAN MATEO, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Jonathan Kennedy to the role of Chief Financial Officer....
Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600 Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600 PR Newswire NEW YORK , July 21, 2022 /PRNewswire/ -- Novanta Inc....
MIDDLETON, Wis., July 21, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight se...